SCHEMBL873523

SCHEMBL873523

O=C[C@H]1CCCO1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4356648 1.00
SCHEMBL21145 1.00
SCHEMBL28116028 1.00 LMNA (0.31)
SCHEMBL3757537 0.97
SCHEMBL2592648 0.97
Water SCHEMBL6323742 0.97
SCHEMBL28633956 0.97 HPGD (0.32)
SCHEMBL6669492 0.97
Hydrochloric Acid SCHEMBL18690254 0.97
SCHEMBL16345221 0.97

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 40 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12441702-B2 Substituted 4-benzyl and 4-benzoyl piperidine derivates CEPHALON LLC (US) 2025-10-14 US claimed
US-11878966-B2 Substituted 4-benzyl and 4-benzoyl piperidine derivates 89BIO LTD (IL) 2024-01-23 US claimed
US-20220081411-A1 Substituted 4-Benzyl And 4-Benzoyl Piperidine Derivates CEPHALON LLC 2022-03-17 US claimed
US-20210371422-A1 MORPHINAN DERIVATIVE NIPPON CHEMIPHAR CO., LTD. (JP) 2021-12-02 US claimed
CN-113329748-A Inhibition of Fatty Acid Synthase (FASN) 福马治疗股份有限公司 2021-08-31 CN claimed
EP-3498711-A1 MORPHINAN DERIVATIVE Nippon Chemiphar Co., Ltd. (JP) 2019-06-19 EP claimed
WO-2008007930-A9 MELANOCORTIN RECEPTOR AGONISTS LG LIFE SCIENCES LTD (KR) 2009-04-02 WO claimed
EP-1318148-B1 Method of preparing optically pure (R)- or (S)- tetrahydrofuranyl ketone SK CORP (KR) 2005-01-12 EP claimed
US-12448392-B2 Spiropiperidine derivatives CEPHALON LLC (US) 2025-10-21 US disclosed
US-12441702-B2 Substituted 4-benzyl and 4-benzoyl piperidine derivates CEPHALON LLC (US) 2025-10-14 US disclosed
WO-2025080946-A2 RAS INHIBITORS Revolution Medicines, Inc. (US) 2025-04-17 WO disclosed
US-20240239812-A1 MACROCYCLIC 2-ALLYLTETRAHYDROFURANS AS INHIBITORS OF MCL-1 JANSSEN PHARMACEUTICA NV (BE) 2024-07-18 US disclosed
US-20240166625-A1 Substituted 4-Benzyl And 4-Benzoyl Piperidine Derivates CEPHALON LLC 2024-05-23 US disclosed
US-11878966-B2 Substituted 4-benzyl and 4-benzoyl piperidine derivates 89BIO LTD (IL) 2024-01-23 US disclosed
US-20090186868-A1 Taxane Compound Having Azetidine Ring Structure DAIICHI SANKYO COMPANY LIMITED (JP) 2009-07-23 US disclosed
US-20090186868-A1 Taxane Compound Having Azetidine Ring Structure DAIICHI SANKYO COMPANY LIMITED (JP) 2009-07-23 US disclosed
US-20090186868-A1 Taxane Compound Having Azetidine Ring Structure DAIICHI SANKYO COMPANY LIMITED (JP) 2009-07-23 US disclosed
WO-2008145616-A1 HETEROCYCLIC COMPOUNDS AS POSITIVE MODULATORS OF METABOTROPIC GLUTAMATE RECEPTOR 2 (MGLU2 RECEPTOR) ABBOTT GMBH & CO. KG (DE) 2008-12-04 WO disclosed
US-20080300260-A1 HETEROCYCLIC COMPOUNDS AS POSITIVE MODULATORS OF METABOTROPIC GLUTAMATE RECEPTOR 2 (MGLU2 receptor) ABBVIE DEUTSCHLAND GMBH & CO KG (DE) 2008-12-04 US disclosed
EP-1942109-A1 TAXANE COMPOUND WITH AZETIDINE RING STRUCTURE Daiichi Sankyo Company, Limited (JP) 2008-07-09 EP disclosed